Improved Bowel Preparation Method for Colonoscopy Based on Different Risk Stratification

NCT04582942 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 2028

Last updated 2022-12-20

No results posted yet for this study

Summary

The purpose of this study is to evaluate the efficacy of polyethylene glycol(PEG) combined with lactulose for bowel preparation before colonoscopy in low-risk patients and high-risk patients.

Conditions

  • Bowel Preparation Before Colonoscopy

Interventions

DRUG

PEG

Patients began to drink 1 L of PEG at 8:00 PM on the day before colonoscopy at a rate of 250 mL every 10- 15 minutes. On the day of the procedure, patients took the remaining 2 L of PEG 4-6 hours before colonoscopy.

DRUG

PEG+lactulose

On the day before colonoscopy , Patients took 45 mL lactulose solution at 7:00 PM. And then Patients began to drink 1 L of PEG at 8:00 PM at a rate of 250 mL every 10- 15 minutes. On the day of the procedure, patients took 45 mL lactulose solution and the remaining 2 L of PEG 4-6 hours before colonoscopy.

Sponsors & Collaborators

  • Hubei Hospital of Traditional Chinese Medicine

    collaborator OTHER
  • Wuhan Central Hospital

    collaborator OTHER
  • Wuhan Third Hospital

    collaborator OTHER
  • The General Hospital of Central Theater Command

    collaborator OTHER
  • The Third People's Hospital of Hubei Province

    collaborator OTHER
  • Wuhan Puren Hospital

    collaborator OTHER
  • Wuhan Puai Hospital

    collaborator UNKNOWN
  • Tian You Hospital Affiliated to Wuhan University of Science and Technology

    collaborator UNKNOWN
  • Wuhan Red Cross Hospital

    collaborator UNKNOWN
  • Renmin Hospital of Wuhan University

    lead OTHER

Principal Investigators

  • Mingkai Chen, M.D · Renmin Hospital of Wuhan University

Study Design

Allocation
RANDOMIZED
Purpose
SCREENING
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-08-06
Primary Completion
2021-08-15
Completion
2021-08-15

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04582942 on ClinicalTrials.gov